Hemogenyx Pharmaceuticals plc is a biopharmaceutical company focused on developing treatments for blood and autoimmune disorders. The company is engaged in the pre-clinical stage of research, aiming to utilize bone marrow transplantation to create therapies for these conditions. Hemogenyx operates primarily in the healthcare sector, targeting patients with specific blood-related diseases.